Recurrent Priapism in a Sickle Cell Disease Patient Treated with Gonadotropin-Releasing Hormone Agonists: A Case Report

    February 2026 in “ The Journal of Sexual Medicine
    A B Pereira de Souza, J G Oliveira Vaz, A Akel Ferruccio, A Salgado Moraes Filho, T Tobias, L Bernardes de Amaro, R Oliveira Lima Silva, L Costa de Salles, V José Massaro Júnior, D Bianqui Guaraldo da Silva, A Canettieri Rubez, R Destro Saad, Adriano Fregonesi
    TLDR GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.
    This case report discusses the treatment of recurrent priapism in a 34-year-old male with sickle cell disease using gonadotropin-releasing hormone (GnRH) agonists. Despite various treatments, including aspirin, hydroxyurea, finasteride, and monthly exchange transfusions, the patient experienced daily painful erections. Oral etilefrine and bicalutamide were ineffective, with the latter causing painful gynecomastia. As a last resort before considering penile prosthesis, the patient was treated with goserelin, a GnRH agonist, which led to significant clinical improvement and cessation of stuttering priapism. The patient regained satisfactory erectile function and opted to continue hormonal therapy. The report highlights the effectiveness of GnRH agonists in managing symptoms and improving quality of life, though it notes the need for further studies on long-term safety.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 12 results

    Similar Research

    5 / 1000+ results